LORAZEPAM
C16626
http://purl.bioontology.org/ontology/NDFRT/C16626
Drug Hypersensitivity
Glaucoma, Angle-Closure
Pregnancy
Sleep Apnea Syndromes
Respiratory Insufficiency
Lorazepam
GABA B Modulators
GABA A Modulators
Increased Central Nervous System GABA Activity
Ingredient
Depressive Disorder
Psychotic Disorders
Status Epilepticus
Anxiety Disorders
Catatonia
Epilepsies, Partial
Sleep Initiation and Maintenance Disorders
Vomiting
Substance Withdrawal Syndrome
NDF_KIND
N0000146205
L [Preparations]
LORAZEPAM 4MG/ML INJ,TUBEX,1ML
LORAZEPAM 4MG/ML INJ
LORAZEPAM 2MG/ML INJ,TUBEX,1ML
LORAZEPAM 2MG/ML INJ,TUBEX,0.5ML
LORAZEPAM 1MG TAB,UD
LORAZEPAM 1MG TAB
LORAZEPAM 0.5MG TAB,UD
LORAZEPAM 0.5MG TAB
LORAZEPAM 2MG/ML INJ,CARPUJECT,1ML
LORAZEPAM 2MG/ML INJ
LORAZEPAM 2MG/ML CONC,ORAL
LORAZEPAM 2MG TAB,UD
LORAZEPAM 2MG TAB
6470
Organic Chemical
Pharmacologic Substance
C0024002
True
4017848